HOME >> BIOLOGY >> NEWS
Florida frontier expedition

FT. PIERCE, Fla., May 20, 2004 -- Scientists from the new state-funded Center of Excellence in Biomedical and Marine Biotechnology will spend the next two weeks exploring never before seen sections of deepwater coral reefs rich with life off Florida's east coast and the Keys. The team, with members from Harbor Branch Oceanographic and Florida Atlantic University, will be using Harbor Branch's Johnson-Sea-Link I submersible and scuba in a search for marine creatures that produce chemicals with the potential to cure human diseases ranging from cancer to Alzheimer's.

Amazingly, vast stretches of vibrant seafloor lay unexplored just a few miles from major ports such as Miami, and the team expects to make important discoveries as they tap these previously hidden biomedical treasure troves for the first time. FAU's Department of Ocean Engineering has been using an unmanned autonomous underwater vehicle (AUV) to map the area and has discovered some of the promising sites that will be explored using the submersible. Regular dispatches from the expedition and photos will be posted at Harbor Branch's @Sea website, www.at-sea.org.

"Based on past work we have every reason to believe that there are cures waiting in Florida waters for a number of diseases, the only limitation has been financial," says Dr. Amy Wright, director of Harbor Branch's Biomedical Marine Research program and a co-leader of the expedition. "Funding like this for the Center of Excellence is essential for pushing this research and Florida's marine biotechnology industry forward."

Similar expeditions by Harbor Branch off Florida and around the world have already yielded numerous chemicals that show great promise in fighting cancer, infections, and other afflictions. One, a compound called discodermolide, has proven an effective cancer cell killer, even in tumors that are resistant to Taxol, one of the best treatments currently available for breast a
'"/>

Contact: Mark Schrope
schrope@hboi.edu
772-216-0390
Harbor Branch Oceanographic Institution
17-May-2004


Page: 1 2 3

Related biology news :

1. Tracing genes, biologists show lizard migration is traced to Florida
2. Florida Tech earns $50,000 grant to create coral database
3. Florida Tech researchers win $912,700 grant for cell studies
4. Exploring the sights and sounds of a deepwater coral marine protected area off Florida
5. Black water turns the tide on Florida coral
6. UCF to host Florida Academy of Sciences meeting
7. Coral smothering green tide seaweed spreading on Florida reefs
8. University of Florida engineers probe shape memory alloy for better prostheses
9. Common bacteria kills elkhorn coral off Florida keys, says UGA research team
10. University of South Florida team conducts trial for HIV vaccine
11. People and fire at Floridas wildland-urban interface

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Florida frontier expedition

(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... July 30, 2015 after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a biometric ... revised version of one of its first 30 second commercials will ... New York , Chicago , ... metro areas.    , , , , ... the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
(Date:7/29/2015)... Inc. (NYSE: BIOA ) today announced that ... resigned.  The Company has hired Andrew Ashworth , ... 2014, as full time interim CFO and has launched ... Andy Ashworth began his employment today, to overlap ... was the Company,s CFO from September 2011 to December ...
(Date:7/29/2015)... July 29, 2015 ... the addition of the "Global Biosimilars Market, ... The Global Biosimilars Market, 2015 - ... rapidly growing biosimilars market. With the blockbuster biologics ... minimize costs, biosimilars are being viewed as viable ...
(Date:7/29/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX) announced today ... released on Thursday, August 13, 2015, before the open ... will host a conference call to discuss the financial ... outlining the financial results and business update will be ... call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference Pfenex ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: